KXRM Colorado Springs on MSN1h
NTSB releases final report on 2023 train derailment
<a ...
Tens of millions of dead people aren’t getting Social Security checks, despite Trump and Musk claims
The Trump administration is falsely claiming that tens of millions of dead people over 100 years old are receiving Social ...
The Taipei Times11h
She said no: marriages in China plummet to record low
Marriages in China last year plunged 20 percent to a record low as young people resisted government efforts to convince them ...
National Observer17h
‘Engine of inequality’: delegates discuss AI’s global impact at Paris summit
The impact of artificial intelligence on the environment and inequality have featured in the opening exchanges of a global ...
Man to plead guilty to 2023 shooting of Black teen Ralph Yarl, 2 people familiar with case tell AP
An 86-year-old Kansas City man will plead guilty Friday to the 2023 shooting of Ralph Yarl, a Black teenager who rang the man's doorbell by mistake, two people familiar with the case told The ...
Bus-Sized Asteroid Approaching Earth Today, NASA Reports
The space rock is heading in our direction at some 18,700 miles per hour, according to the space agency's data.
Hate speech on X now 50% higher under Elon Musk’s leadership, new study finds
A new study by the University of California, Berkeley found that hate speech rose by 50 per cent in the months after ...
NASA says that, yes, an asteroid buzzing by in 2023 could hit Earth
An asteroid that measures up to 300 feet across could smack into Earth in 2032, and while NASA says the chances of a ...
An asteroid could hit Earth in 7 years. Here's how astronomers are tracking it
Over the next several weeks, astronomers will be looking closely at an asteroid called 2024 YR4 that could be as big as a ...
WWNO6d
How do astronomers track asteroids that could threaten Earth?
Over the next several weeks, astronomers will be looking closely at an asteroid called 2024 YR4 that could be as big as a ...
Mereo BioPharma: Good Science, Fairly Valued
Mereo BioPharma shifts focus to rare diseases with setrusumab showing strong results for Osteogenesis Imperfecta. Learn more on MREO stock here.